Posted inEmerging Market
Logistics Giants Scale Up Cold Storage as GLP-1 Demand Drives Healthcare Supply Chain Boom
Logistics giants are expanding temperature-controlled networks to meet the surging demand for cold storage driven by GLP-1 drugs.
Posted inEmerging Market
Novo Nordisk Sues Eli Lilly Over Alleged Misleading GLP-1 Advertising
Danish pharmaceutical giant Novo Nordisk filed a federal lawsuit against rival Eli Lilly, alleging that the American drugmaker engaged in false and deceptive advertising regarding its popular GLP-1 class of…
Posted inBusiness Insights
Eli Lilly’s Next-Generation Weight-Loss Drug Clears Critical Heart Safety Hurdle
Pharmaceutical giant Eli Lilly & Co. announced this week that its experimental, next-generation weight-loss therapy demonstrated no overall increase in cardiovascular risk in a major clinical evaluation, successfully clearing a…
Posted inEmerging Market
Tiny Under-the-Skin Implant Challenges Weekly Weight-Loss Injections
Discover how a tiny twice yearly subdermal implant delivering semaglutide could replace weekly weight loss injections and prevent weight rebound.
Posted inEmerging Market
Medicare’s Landmark Coverage Shift: What Seniors Need to Know About Obesity Drug Access
Medicare now covers obesity drugs for heart health; learn how this landmark policy shift impacts your access to life-changing medication.
